Status:
TERMINATED
Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Idiopathic pulmonary fibrosis (IPF), a chronic fibrotic lung disease of unknown cause, is characterized by relentless progression, with a three-year mortality of up to 50%. IPF has high morbidity, wit...
Detailed Description
The hypothesis is that the provision of a comprehensive pulmonary rehabilitation program to patients with IPF will significantly improve participant health related quality of life. The objective is to...
Eligibility Criteria
Inclusion
- Diagnosis of IPF confirmed by lung biopsy or by characteristic pattern on high resolution computed tomogram (HRCT)
- No identifiable cause of lung fibrosis
- PR not received in the past year
- Ability to walk
Exclusion
- History of unstable angina
- Deterioration cardiac or neurological disease
- Pregnancy or lactation
- Degenerative arthritis or other limitation to mobility
- PR in the past 12 months
Key Trial Info
Start Date :
September 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03480451
Start Date
September 12 2017
End Date
February 1 2019
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, United States, 53226